Regulation of the Innate Immune Response by the Epithelium in Asthma

哮喘中上皮细胞对先天免疫反应的调节

基本信息

批准号：
10160631
负责人：
TEAL S HALLSTRAND
金额：
$ 11.17万
依托单位：
BENAROYA RESEARCH INST AT VIRGINIA MASON
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-05-14 至 2021-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10160631
关键词：
2019-nCoV Address Adhesions Administrative Supplement Adult Affect Age Age-Years Air Allergens Allergic Asthma Biological Models COVID-19 Case Fatality Rates Cell Culture Techniques Cell Death Cells Child Coronavirus Cytoskeleton Data Deposition Development Diabetes Mellitus Disease Elderly Epithelial Epithelial Cells Epithelium Exhibits Extracellular Matrix Failure Fatality rate Genes Genetic Genetic Screening Goals Grant Heterogeneity Hypertension Immune Immune response Incidence Individual Infection Infiltration Inflammatory Innate Immune Response Integrin alphaV Interferon Type I Interferons Leukocytes Liquid substance Lung Mind Mutagenesis Obesity Older Population Parents Pathogenicity Pathway interactions Patients Play Pneumonia Positioning Attribute Predisposition Primary Infection Process Production Reagent Regulation Resistance Resources Respiratory Failure Respiratory Syncytial Virus Infections Role SARS coronavirus Sampling Severities Severity of illness Social Distance Symptoms T cell response T-Lymphocyte Techniques Testing Therapeutic Tissues Viral Virus Virus Diseases Virus Replication Virus Shedding Virus-Cell Membrane Interaction Work adaptive immune response age group airway epithelium asthmatic asthmatic airway chemokine cohort comorbidity cytokine high risk human coronavirus improved infection rate lung injury monocyte novel therapeutics pandemic disease parent grant prevent programs recruit respiratory infection virus respiratory virus response therapeutic target tissue injury virus host interaction

项目摘要

Project Summary It is well known that infection by respiratory viruses (e.g., RSV or RV) can exacerbate responses in individuals who are allergic asthmatics. It is our hypothesis that the airway epithelium is the central coordinator of responses to respiratory virus infection, as well as to allergens. Intrinsic differences in airway epithelial cells (AEC) in healthy and asthmatic individuals play an important role in this exacerbated response. AECs from asthmatics respond in a different manner to infection than AECs from healthy subjects. These differences are manifested during infection in several ways, including changes in the expression and deposition of extra cellular matrix components and qualitative and quantitative differences in the expression of cytokines and chemokines. This altered response in asthmatic AEC leads to changes in both innate and adaptive responses during infection, with increased infiltration of the airways with leukocytes. The primary goal of this Program is to identify and characterize these changes in asthmatic AECs, and determine their effects on the innate and adaptive immune response. With this goal in mind, we will (1) Determine the role of the epithelium in regulating ECM and leukocyte adhesion in viral-triggered asthma; (2) Determine the regulation of the Innate Immune response by the epithelium in asthma; (3) Determine the role of the epithelium in regulating T cell responses in asthma.

项目摘要众所周知，呼吸道病毒感染（例如RSV或RV）会加剧个体的反应谁是过敏性哮喘患者。我们的假设是气道上皮是对呼吸道病毒感染以及过敏原的反应。气道上皮细胞的内在差异（AEC）在健康和哮喘患者中，在这种加剧的反应中起着重要作用。 AEC来自哮喘患者对感染的反应与健康受试者的AEC相比。这些差异是在感染过程中以多种方式表现出来，包括额外的表达和沉积变化细胞基质成分以及细胞因子表达和定量差异和定量差异趋化因子。哮喘AEC的反应改变导致先天和适应性反应的变化在感染过程中，随着白细胞的气道渗透增加。该程序的主要目标是识别和表征哮喘AEC中的这些变化，并确定它们对先天和自适应免疫反应。考虑到这个目标，我们将（1）确定上皮在调节病毒触发哮喘中的ECM和白细胞粘附；（2）确定调节上皮在哮喘中的先天免疫反应；（3）确定上皮在调节哮喘中T细胞反应。